AIBODY

AIBODY is a UK-based startup with a vision to create the only digital human organism in the world. Founded in 2016, AIBODY has garnered attention for its innovative approach in merging education and healthcare industries. The company's pioneering venture has attracted the interest of Raw Ventures, who participated in the latest funding round on 18th March 2021. AIBODY's slogan, "The only digital human organism in the world," encapsulates the ambitious goal of the startup, which is to replicate the complexities of human physiology in a digital form. The multidisciplinary team, comprised of medical professionals and technology experts, has developed a platform that offers accelerated teaching of human physiology to clinical personnel, empowers medical technology solutions, and serves as a valuable tool for pharma companies to streamline R&D and clinical programs. The intersection of medicine and technology is a burgeoning field, and AIBODY has positioned itself as a pioneering force with the potential to disrupt traditional approaches in the education and healthcare sectors. The recent investment from Raw Ventures not only signifies confidence in AIBODY's vision but also highlights the potential for groundbreaking advancements in the digital representation of the human body.